Lee Sang Ah, Cho Dong-Hyuk, Choi Jimi, Gwon Jun Gyo
Department of Surgery, Division of Vascular Surgery, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.
Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Ann Thorac Cardiovasc Surg. 2025;31(1). doi: 10.5761/atcs.oa.24-00177.
Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are both well-established treatments for carotid artery stenosis. We analyzed real-world data from the Korean National Health Insurance Service (NHIS) database to compare the clinical outcomes.
This retrospective cohort study included patients with carotid artery stenosis registered in the NHIS from 2008 to 2018. Patients who underwent either treatment were divided into CEA or CAS groups and subjected to 1:4 propensity score matching.
The study cohort included 1521 CEA and 6768 CAS patients. In symptomatic patients, the stroke rate within 1 month was lower in the CAS group (hazard ratio [HR], 0.61). However, the incidence of cardiovascular disease (CVD) death was higher in the CAS group at 1 month, 1 year, and during the total follow-up (HRs, 4.18, 2.43, and 1.50). There were no significant differences in outcomes between asymptomatic patients in the 2 groups.
The periprocedural stroke risk was higher in symptomatic carotid stenosis patients who underwent CEA, but mortality was higher in those who received CAS, both in the short and long term. In asymptomatic patients, however, the incidence of major adverse cardiovascular events and mortality was similar between the 2 groups.
颈动脉内膜切除术(CEA)和颈动脉支架置入术(CAS)都是治疗颈动脉狭窄的成熟方法。我们分析了韩国国民健康保险服务(NHIS)数据库中的真实世界数据,以比较临床结果。
这项回顾性队列研究纳入了2008年至2018年在NHIS登记的颈动脉狭窄患者。接受任何一种治疗的患者被分为CEA组或CAS组,并进行1:4倾向评分匹配。
研究队列包括1521例CEA患者和6768例CAS患者。在有症状的患者中,CAS组1个月内的卒中率较低(风险比[HR],0.61)。然而,CAS组在1个月、1年及整个随访期间的心血管疾病(CVD)死亡率较高(HR分别为4.18、2.43和1.50)。两组无症状患者的结局无显著差异。
接受CEA的有症状颈动脉狭窄患者围手术期卒中风险较高,但接受CAS的患者短期和长期死亡率均较高。然而,在无症状患者中,两组主要不良心血管事件的发生率和死亡率相似。